TGF-β signaling by Smad proteins

Cytokine and Growth Factor Reviews

Volumn 11, Issue 1-2, 2000, Pages 15-22

  Miyazono, Kohei ^a  

^a CANCER INSTITUTE   (Japan)

Author keywords

Adenoviral expression vector; BMP; Smad; TGF ; Transcription

Indexed keywords

BMP RECEPTOR; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; CELL SURFACE RECEPTOR; DNA BINDING PROTEIN; E1A-ASSOCIATED P300 PROTEIN; NUCLEAR PROTEIN; ONCOPROTEIN; PHOSPHOPROTEIN; PROTO-ONCOGENE PROTEIN SKI; SMAD PROTEIN; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD6 PROTEIN; SMAD7 PROTEIN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ADENOVIRUS; ANIMAL; CELL DIFFERENTIATION; CELL NUCLEUS; CYTOLOGY; DRUG EFFECT; EXPRESSION VECTOR; GENE TARGETING; GENETICS; HUMAN; INTRACELLULAR TRANSPORT; METABOLISM; NONHUMAN; OSTEOBLAST; PROTEIN DNA BINDING; REPRESSOR GENE; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ADENOVIRIDAE; ANIMALS; BONE MORPHOGENETIC PROTEIN RECEPTORS; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELL NUCLEUS; DNA-BINDING PROTEINS; HUMANS; NUCLEAR PROTEINS; OSTEOBLASTS; PHOSPHOPROTEINS; PROTO-ONCOGENE PROTEINS; RECEPTORS, CELL SURFACE; RECEPTORS, GROWTH FACTOR; SIGNAL TRANSDUCTION; SMAD PROTEINS; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD6 PROTEIN; SMAD7 PROTEIN; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA;

ADENOVIRIDAE; ANIMALIA;

EID: 0034030142     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(99)00025-8     Document Type: Review

References (42)

1. Heldin C.-H., Miyazono K., ten Dijke P. TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature. 390:1997;465-471.
2. Massagué J. TGF-β signal transduction. Annu. Rev. Biochem. 67:1998;753-791.
3. Miyazono K, Ten Dijke P, Heldin C-H. TGF-β signaling by Smad proteins. Adv Immunol (in press), 2000
4. Katagiri T., Yamaguchi A., Komaki M., Abe E., Takahashi N., Ikeda T., Rosen V., Wozney J.M., Fujisawa-Sehara A., Suda T. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J. Cell. Biol. 127:1994;1755-1766.
5. Takeda K., Ichijo H., Fujii M., Mochida Y., Saitoh M., Nishitoh H., Sampath T.K., Miyazono K. Identification of a novel bone morphogenetic protein-responsive gene that may function as a noncoding RNA. J. Biol. Chem. 273:1998;17,079-17,085.
6. Ebisawa T., Tada K., Kitajima I., Tojo A., Samapth T.K., Kawabata M., Miyazono K., Imamura T. Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation. J. Cell. Sci. 112:1999;3519-3527.
7. Fujii M, Takeda K, Imamura T, Sampath TK, Enomoto S, Kawabata M, Kato M, Ichijo H, Miyazono K. Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblastic and chondroblastic differentiation. Mol Biol Cell 1999;10:3801-13
8. Kawabata M., Imamura T., Miyazono K. Signal transduction by bone morphogenetic proteins. Cytokine Growth Factor Rev. 9:1998;49-61.
9. ten Dijke P., Yamashita H., Sampath T.K., Reddi A.H., Estevez M., Riddle D.L., Ichijo H., Heldin C.-H., Miyazono K. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J. Biol. Chem. 269:1994;16,985-16,988.
10. Macías-Silva M., Hoodless P.A., Tang S.J., Buchwald M., Wrana J.L. Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2. J. Biol. Chem. 273:1998;25,628-25,636.
11. Itoh S., Landström M., Hermansson A., Itoh F., Heldin C.-H., Heldin N.-E., ten Dijke P. Transforming growth factor β1 induces nuclear export of inhibitory Smad7. J. Biol. Chem. 273:1998;29,195-29,201.
12. Shukunami C., Shigeno C., Atsumi T., Ishizeki K., Suzuki F., Hiraki Y. Chondrogenic differentiation of clonal mouse embryonic cell line ATDC5 in vitro: differentiation-dependent gene expression of parathyroid hormone (PTH)/PTH-related peptide receptor. J. Cell. Biol. 133:1996;457-468.
13. Asahina I., Sampath T.K., Nishimura I., Hauschka P.V. Human osteogenic protein-1 induces both chondroblastic and osteoblastic differentiation of osteoprogenitor cells derived from newborn rat calvaria. J. Cell. Biol. 123:1993;921-933.
14. Nakamura K., Shirai T., Morishita S., Uchida S., Saeki-Miura K., Makishima F. p38 mitogen-activated protein kinase functionally contributes to chondrogenesis induced by growth/differentiation factor-5 in ATDC5 cells. Exp. Cell. Res. 250:1999;351-363.
15. Nakao A., Fujii M., Matsumura R., Kumano K., Saito Y., Miyazono K., Iwamoto I. Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. J. Clin. Invest. 104:1999;5-11.
16. Zawel L., Le Dai J., Buckhaults P., Zhou S., Kinzler K.W., Vogelstein B., Kern S.E. Human Smad3 and Smad4 are sequence-specific transcription activators. Mol. Cell. 1:1998;611-617.
17. Dennler S., Itoh S., Vivien D., ten Dijke P., Huet S., Gauthier J.M. Direct binding of Smad3 and Smad4 to critical TGFβ-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17:1998;3091-3100.
18. Jonk L.J.C., Itoh S., Heldin C.-H., ten Dijke P., Kruijer W. Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-β, activin, and bone morphogenetic protein-inducible enhancer. J. Biol. Chem. 273:1998;21,145-21,152.
19. Takenoshita S., Mogi A., Nagashima M., Yang K., Yagi K., Hanyu A., Nagamachi Y., Miyazono K., Hagiwara K. Characterization of MADH2/Smad2 gene, a human Mad homolog responsible for transforming growth factor-β and activin signal transduction pathway. Genomics. 48:1998;1-11.
20. Yagi K., Goto D., Hamamoto T., Takenoshita S., Kato M., Miyazono K. Alternatively-spliced variant of Smad2 lacking exon 3: comparison with wild-type Smad2 and Smad3. J. Biol. Chem. 274:1999;703-709.
21. Dennler S., Huet S., Gauthier J.M. A short amino-acid sequence in MH1 domain is responsible for functional differences between Smad2 and Smad3. Oncogene. 18:1999;1643-1648.
22. Labbé E., Silvestri C., Hoodless P.A., Wrana J.L., Attisano L. Smad2 and Smad3 positively and negatively regulate TGFβ-dependent transcription through the forkhead DNA-binding protein FAST2. Mol. Cell. 2:1998;109-120.
23. Yanagisawa J., Yanagi Y., Masuhiro Y., Suzawa M., Toriyabe T., Kashiwagi K., Watanabe M., Kawabata M., Miyazono K., Kato S. Convergence of transforming growth factor-β and vitamin D signaling pathways on Smad transcriptional coactivators. Science. 283:1999;1317-1321.
24. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 89:1997;755-764.
25. Otto F., Thornell A.P., Crompton T., Denzel A., Gilmour K.C., Rosewell I.R., et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell. 89:1997;765-771.
26. Okuda T., van Deursen J., Hiebert S.W., Grosveld G., Downing J.R. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell. 84:1996;321-330.
27. Shi M.J., Stavnezer J. CBFα3 (AML2) is induced by TGF-β1 to bind and activate the mouse germline Ig α promoter. J. Immunol. 161:1998;6751-6760.
28. Hanai J.-i, Chen L.F., Kanno T., Ohtani-Fujita N., Kim W.Y., Guo W.-H., et al. Interaction and functional cooperation of PEBP2/CBF with Smads: synergistic induction of the immunoglobulin germline Cα promoter. J. Biol. Chem. 274:1999;31,577-31,582.
29. Pardali E, Xie X-Q, Itoh S, Konstantinos A, Panagiotis T, Heldin C-H, Ten Dijke P, Grundström T, Sideras P. Smad and AML proteins synergistically confer TGFβ1 responsiveness of human germ-line IgA genes. J Biol Chem (in press), 2000
30. Nishihara A., Hanai J.-i, Okamoto N., Yanagisawa J., Kato S., Miyazono K., Kawabata M. Role of p300, a transcriptional coactivator, in signalling of TGF-β Gene Cells. 3:1998;613-623.
31. Feng X.-H., Zhang Y., Wu R.Y., Derynck R. The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for Smad3 in TGF-β-induced transcriptional activation. Genes Dev. 12:1998;2153-2163.
32. Janknecht R., Wells N.J., Hunter T. TGF-β-stimulated cooperation of Smad proteins with the coactivators CBP/p300. Genes Dev. 12:1998;2114-2119.
33. Pouponnot C., Jayaraman L., Massagué J. Physical and functional interaction of Smads and p300/CBP. J. Biol. Chem. 273:1998;22,865-22,868.
34. Shen X., Hu P.P., Liberati N.T., Datto M.B., Frederick J.P., Wang X.-F. TGF-β-induced phosphorylation of Smad3 regulates its interaction with coactivator p300/CREB-binding protein. Mol. Biol. Cell. 9:1998;3309-3319.
35. Nishihara A., Hanai J.-i, Imamura T., Miyazono K., Kawabata M. E1A inhibits transforming growth factor-β signaling through binding to Smad proteins. J. Biol. Chem. 274:1999;28,716-28,723.
36. Nakashima K., Yanagisawa M., Arakawa H., Kimura N., Hisatsune T., Kawabata M., Miyazono K., Taga T. Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300. Science. 284:1999;479-482.
37. Wotton D., Lo R.S., Lee S., Massagué J. A Smad transcriptional corepressor. Cell. 97:1999;29-39.
38. Nomura T., Khan M.M., Kaul S.C., Dong H.-D., Wadhwa R., Colmenares C., Kohno I., Ishii I. Ski is a component of the histone deacetylase complex required for transcriptional repression by Mad and thyroid hormone receptor. Genes Dev. 13:1999;412-423.
39. Akiyoshi S, Inoue H, Hanai J-i, Kusanagi K, Nemoto N, Miyazono K, Kawabata M. c-Ski acts as a transcriptional co-repressor in TGF-β signaling through interaction with Smads. J Biol Chem 1999;274:35269-77
40. Luo K., Stroschein S.L., Wang W., Chen D., Martens E., Zhou S., Zhou Q. The Ski oncoprotein interacts with the Smad proteins to repress TGF-β signaling. Genes Dev. 13:1999;2196-2206.
41. Sun Y., Liu X., Eaton E.N., Lane W.S., Lodish H.F., Weinberg R.A. Interaction of the Ski oncoprotein with Smad3 regulates TGF-β signaling. Mol. Cell. 4:1999;499-509.
42. Stroschein S.L., Wang W., Zhou S., Zhou Q., Luo K. Negative feedback regulation of TGF-β signaling by the SnoN oncoprotein. Science. 286:1999;771-774.